Retatrutide 50MG
$238.00
Retatrutide 50MG is a 50-milligram format of retatrutide, a synthetic peptide investigated as a multi receptor agonist. Researchers study retatrutide in preclinical and clinical settings related to incretin and glucagon receptor signaling and downstream metabolic endpoints. Studies have examined its pharmacology using receptor binding and pathway activation assays.
In Stock
Retatrutide 50MG is a 50-milligram format of retatrutide, a synthetic peptide investigated as a multi receptor agonist in research involving incretin and glucagon family receptors. Published studies have examined retatrutide using in vitro signaling models and in vivo pharmacology frameworks to characterize receptor engagement, exposure response relationships, and biomarker changes.
Retatrutide 50MG is of interest to researchers working on peptide hormone analog design, receptor selectivity, and metabolic disease models where GLP-1, GIP, and glucagon pathways are commonly evaluated. Analytical workflows often include identity confirmation by mass spectrometry and purity assessment by chromatography prior to experimental use.
- Specification: 50MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Trenbolone Enanthate (Tre) 100mg/ml 10ml is an oil based preparation of trenbolone enanthate, a synthetic anabolic androgenic steroid ester derived from 19 nor testosterone chemistry. Researchers may reference trenbolone esters in studies involving androgen receptor signaling, nitrogen balance models, and steroid pharmacokinetics. This format is commonly discussed in analytical and method development work where concentration and volume are specified.
In Stock
Cagrilintide + Semaglutide 5MG is a 5-milligram combined format of two peptide research compounds: cagrilintide (an amylin analogue) and semaglutide (a GLP 1 receptor agonist peptide analogue). Researchers study this pairing in preclinical and clinical research settings focused on appetite regulation and metabolic signaling. Studies have examined how amylin and GLP 1 pathways may interact when investigated together.
In Stock
Semaglutide 5MG is a 5-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is studied as an acylated peptide engineered for extended stability in biological systems. Researchers have examined semaglutide in preclinical and translational work involving incretin signaling and metabolic regulation pathways.
In Stock
Tirzepatide 15MG is a 15-milligram format of tirzepatide, a synthetic peptide studied as a dual agonist at the GIP and GLP 1 receptors. It is of interest in metabolic and endocrine research where incretin signaling is examined. Studies have evaluated tirzepatide in preclinical and clinical settings to better understand receptor bias, signaling kinetics, and downstream biomarker changes.
In Stock
Tirzepatide 20MG is a 20-milligram format of tirzepatide, a synthetic peptide studied as a dual GIP and GLP 1 receptor agonist. Researchers examine tirzepatide in metabolic research, including models related to glycemic regulation, appetite signaling, and energy balance.
In Stock
Trenbolone Hexahydrobenzyl Carbonate – 100mg/ml, 10ml is a specified format of trenbolone hexahydrobenzyl carbonate, a long ester derivative of trenbolone, a synthetic anabolic androgenic steroid (19 nor testosterone analogue). It is studied analytically in steroid ester profiling, reference standard comparison, and method development using chromatographic and mass spectrometric techniques.
In Stock
Semaglutide 20MG is a 20 milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is a 31 amino acid peptide modified for extended stability, and it is widely used in laboratory work involving incretin signaling and metabolic regulation. Researchers study semaglutide in preclinical and translational settings related to glucose homeostasis, appetite pathways, and receptor pharmacology.
In Stock
Winstrol 100mg/ml 10ml refers to a 100 milligram per millilitre concentration supplied in a 10 millilitre format of stanozolol, a synthetic anabolic androgenic steroid derived from dihydrotestosterone. Researchers may reference stanozolol in studies involving androgen receptor signaling, anabolic steroid structure activity relationships, and metabolism profiling.
In Stock
Semaglutide 10MG is a 10-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. Researchers study semaglutide in receptor pharmacology and metabolic signaling research, including models examining appetite regulation and glucose homeostasis. It is also used in assay development and method validation where GLP 1 pathway engagement is of interest.
In Stock
Cagrilintide 10MG is a 10-milligram format of cagrilintide, a long acting amylin analogue peptide designed to engage amylin receptor pathways. Researchers study cagrilintide in preclinical and translational settings involving appetite signalling, gastric emptying models, and metabolic regulation.
In Stock
Trenbolone Enanthate (Tre) 200mg/ml 10ml is a concentration and volume format of trenbolone enanthate, a synthetic anabolic androgenic steroid and esterified analogue of trenbolone. Researchers may use trenbolone esters in laboratory work involving androgen receptor signaling, steroid metabolism, and analytical reference testing.
In Stock
Trenbolone Acetate (Tra) 100mg/ml 10ml is a specified concentration and volume format of trenbolone acetate, an acetate ester of trenbolone and a synthetic anabolic androgenic steroid. Researchers may reference trenbolone acetate in studies involving androgen receptor signaling, steroid ester pharmacokinetics, and analytical method development. It is also encountered in forensic and anti doping research workflows focused on steroid identification.
In Stock
